DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
ATP-dependent translocase ABCB1 (ABCB1)
|
OTEJROBO
|
MDR1_HUMAN
|
Increases Expression
|
[32] |
Equilibrative nucleoside transporter 1 (SLC29A1)
|
OTLOOZZS
|
S29A1_HUMAN
|
Decreases Response To Substance
|
[33] |
GTP-binding protein 1 (GTPBP1)
|
OTA9KV6C
|
GTPB1_HUMAN
|
Increases Expression
|
[17] |
Kinetochore protein NDC80 homolog (NDC80)
|
OTS7D306
|
NDC80_HUMAN
|
Increases Expression
|
[17] |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (PDE6D)
|
OTIFVXWD
|
PDE6D_HUMAN
|
Decreases Expression
|
[17] |
Lymphocyte antigen 75 (LY75)
|
OTDHBU0N
|
LY75_HUMAN
|
Increases Expression
|
[17] |
ATP-dependent DNA helicase Q5 (RECQL5)
|
OTVZMP1Q
|
RECQ5_HUMAN
|
Decreases Expression
|
[17] |
SLIT and NTRK-like protein 5 (SLITRK5)
|
OTTSUSB8
|
SLIK5_HUMAN
|
Decreases Expression
|
[17] |
Dihydrofolate reductase (DHFR)
|
OT3DVIGM
|
DYR_HUMAN
|
Increases Expression
|
[17] |
Alpha-1-antitrypsin (SERPINA1)
|
OTACYW9J
|
A1AT_HUMAN
|
Increases Expression
|
[17] |
T-cell surface glycoprotein CD8 alpha chain (CD8A)
|
OTDWQJXK
|
CD8A_HUMAN
|
Increases Expression
|
[17] |
Thy-1 membrane glycoprotein (THY1)
|
OTVONVTB
|
THY1_HUMAN
|
Decreases Expression
|
[17] |
Serglycin (SRGN)
|
OTFAVSX0
|
SRGN_HUMAN
|
Increases Expression
|
[17] |
Non-secretory ribonuclease (RNASE2)
|
OT8Z4FNE
|
RNAS2_HUMAN
|
Increases Expression
|
[17] |
Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A)
|
OT0OUDUT
|
FCG2A_HUMAN
|
Increases Expression
|
[17] |
Heat shock 70 kDa protein 6 (HSPA6)
|
OTH4S7WB
|
HSP76_HUMAN
|
Increases Expression
|
[17] |
Transcription factor E3 (TFE3)
|
OTM99ZWH
|
TFE3_HUMAN
|
Increases Expression
|
[17] |
Protein S100-P (S100P)
|
OTJCXNJG
|
S100P_HUMAN
|
Increases Expression
|
[17] |
Ribonucleoside-diphosphate reductase subunit M2 (RRM2)
|
OTOB6J6R
|
RIR2_HUMAN
|
Increases Expression
|
[17] |
Low affinity immunoglobulin gamma Fc region receptor II-c (FCGR2C)
|
OTNLMNYB
|
FCG2C_HUMAN
|
Increases Expression
|
[17] |
G protein-coupled receptor kinase 5 (GRK5)
|
OTJK79EK
|
GRK5_HUMAN
|
Increases Expression
|
[17] |
RNA-binding protein 34 (RBM34)
|
OTX3LUGI
|
RBM34_HUMAN
|
Decreases Expression
|
[17] |
Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)
|
OT6E2OW6
|
ENTP1_HUMAN
|
Increases Expression
|
[17] |
Tumor necrosis factor ligand superfamily member 10 (TNFSF10)
|
OT4PXBTA
|
TNF10_HUMAN
|
Increases Expression
|
[17] |
Breast cancer type 2 susceptibility protein (BRCA2)
|
OTF1XSV1
|
BRCA2_HUMAN
|
Increases Expression
|
[17] |
Geranylgeranyl transferase type-2 subunit beta (RABGGTB)
|
OTZ25I2W
|
PGTB2_HUMAN
|
Decreases Expression
|
[17] |
UV excision repair protein RAD23 homolog A (RAD23A)
|
OTBPAWHX
|
RD23A_HUMAN
|
Decreases Expression
|
[17] |
Ras-related protein Rab-5B (RAB5B)
|
OT06PN42
|
RAB5B_HUMAN
|
Increases Expression
|
[17] |
C-X-C chemokine receptor type 4 (CXCR4)
|
OTUFSBX2
|
CXCR4_HUMAN
|
Increases Expression
|
[17] |
Lysozyme C (LYZ)
|
OTD7H0G6
|
LYSC_HUMAN
|
Increases Expression
|
[17] |
Histone H4 (H4C1)
|
OTB71W46
|
H4_HUMAN
|
Decreases Expression
|
[17] |
DNA repair protein RAD51 homolog 1 (RAD51)
|
OTNVWGC1
|
RAD51_HUMAN
|
Increases Expression
|
[17] |
Dual specificity protein phosphatase 4 (DUSP4)
|
OT6WAO12
|
DUS4_HUMAN
|
Decreases Expression
|
[17] |
Src-like-adapter (SLA)
|
OTV17DY2
|
SLAP1_HUMAN
|
Increases Expression
|
[17] |
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (ACAP1)
|
OTPFQ2QC
|
ACAP1_HUMAN
|
Increases Expression
|
[17] |
Cytohesin-1 (CYTH1)
|
OTYH9NRJ
|
CYH1_HUMAN
|
Increases Expression
|
[17] |
C3a anaphylatoxin chemotactic receptor (C3AR1)
|
OT8J0TF8
|
C3AR_HUMAN
|
Increases Expression
|
[17] |
Drebrin (DBN1)
|
OTZVKG8A
|
DREB_HUMAN
|
Decreases Expression
|
[17] |
DALR anticodon-binding domain-containing protein 3 (DALRD3)
|
OTU79VIP
|
DALD3_HUMAN
|
Decreases Expression
|
[17] |
Equilibrative nucleobase transporter 1 (SLC43A3)
|
OTR60ZLA
|
S43A3_HUMAN
|
Increases Expression
|
[17] |
Glutathione S-transferase C-terminal domain-containing protein (GSTCD)
|
OTIIINMT
|
GSTCD_HUMAN
|
Increases Expression
|
[17] |
DENN domain-containing protein 1A (DENND1A)
|
OTONDAA0
|
DEN1A_HUMAN
|
Increases Expression
|
[17] |
Serine protease FAM111A (FAM111A)
|
OTVLARLG
|
F111A_HUMAN
|
Increases Expression
|
[17] |
Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2)
|
OTG6F93V
|
PPIP2_HUMAN
|
Decreases Expression
|
[17] |
Partitioning defective 6 homolog alpha (PARD6A)
|
OTWLV3X1
|
PAR6A_HUMAN
|
Decreases Expression
|
[17] |
Mediator of RNA polymerase II transcription subunit 9 (MED9)
|
OT59OKEJ
|
MED9_HUMAN
|
Decreases Expression
|
[17] |
Phospholipid-transporting ATPase VD (ATP10D)
|
OT3JPE4H
|
AT10D_HUMAN
|
Increases Expression
|
[17] |
Bridging integrator 2 (BIN2)
|
OT4S45WJ
|
BIN2_HUMAN
|
Increases Expression
|
[17] |
DNA dC->dU-editing enzyme APOBEC-3B (APOBEC3B)
|
OTHLNI51
|
ABC3B_HUMAN
|
Increases Expression
|
[17] |
Protein PRRC2C (PRRC2C)
|
OTBX3MXM
|
PRC2C_HUMAN
|
Decreases Expression
|
[17] |
Odontogenic ameloblast-associated protein (ODAM)
|
OTT666SJ
|
ODAM_HUMAN
|
Decreases Expression
|
[18] |
Pleckstrin homology domain-containing family G member 3 (PLEKHG3)
|
OTF6I8RV
|
PKHG3_HUMAN
|
Decreases Expression
|
[18] |
Aldo-keto reductase family 1 member B15 (AKR1B15)
|
OTUEXSWH
|
AK1BF_HUMAN
|
Decreases Expression
|
[18] |
Alternative prion protein (PRNP)
|
OTE85L1Q
|
APRIO_HUMAN
|
Decreases Expression
|
[18] |
Matrilin-2 (MATN2)
|
OTVDR68G
|
MATN2_HUMAN
|
Decreases Expression
|
[18] |
Homeobox protein Meis1 (MEIS1)
|
OTH9DKAD
|
MEIS1_HUMAN
|
Increases Expression
|
[18] |
Gamma-aminobutyric acid receptor subunit pi (GABRP)
|
OTGKA8WS
|
GBRP_HUMAN
|
Increases Expression
|
[18] |
Podocalyxin (PODXL)
|
OTPNQXF3
|
PODXL_HUMAN
|
Decreases Expression
|
[18] |
Sarcolipin (SLN)
|
OTERIU75
|
SARCO_HUMAN
|
Decreases Expression
|
[18] |
Nuclear factor 1 B-type (NFIB)
|
OTX94PD0
|
NFIB_HUMAN
|
Increases Expression
|
[18] |
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF1)
|
OTFK8KDP
|
NHRF1_HUMAN
|
Decreases Expression
|
[18] |
Heparan sulfate glucosamine 3-O-sulfotransferase 1 (HS3ST1)
|
OT5DVN9P
|
HS3S1_HUMAN
|
Decreases Expression
|
[18] |
Tetraspanin-4 (TSPAN4)
|
OTKFK57F
|
TSN4_HUMAN
|
Decreases Expression
|
[18] |
Regulator of G-protein signaling 13 (RGS13)
|
OTPAMQ18
|
RGS13_HUMAN
|
Decreases Expression
|
[18] |
Surfeit locus protein 4 (SURF4)
|
OTCSXJ9C
|
SURF4_HUMAN
|
Decreases Expression
|
[18] |
Monocarboxylate transporter 4 (SLC16A3)
|
OTDIXEXY
|
MOT4_HUMAN
|
Decreases Expression
|
[18] |
Prolyl 4-hydroxylase subunit alpha-2 (P4HA2)
|
OTP45YKX
|
P4HA2_HUMAN
|
Decreases Expression
|
[18] |
Glycogenin-2 (GYG2)
|
OTAJ7YEW
|
GLYG2_HUMAN
|
Decreases Expression
|
[18] |
Fatty acid-binding protein, brain (FABP7)
|
OTRE2H4G
|
FABP7_HUMAN
|
Increases Expression
|
[18] |
Leucine-rich repeat transmembrane protein FLRT2 (FLRT2)
|
OTGD8TID
|
FLRT2_HUMAN
|
Decreases Expression
|
[18] |
SLIT-ROBO Rho GTPase-activating protein 3 (SRGAP3)
|
OT9ZS72C
|
SRGP3_HUMAN
|
Increases Expression
|
[18] |
Homeobox protein Hox-A2 (HOXA2)
|
OT6G6ZIK
|
HXA2_HUMAN
|
Increases Expression
|
[18] |
Mothers against decapentaplegic homolog 6 (SMAD6)
|
OTUZZWUD
|
SMAD6_HUMAN
|
Decreases Expression
|
[18] |
Carbonic anhydrase 12 (CA12)
|
OT6WNFU8
|
CAH12_HUMAN
|
Decreases Expression
|
[18] |
Zinc finger protein SNAI2 (SNAI2)
|
OT7Y8EJ2
|
SNAI2_HUMAN
|
Decreases Expression
|
[18] |
Transcription factor 21 (TCF21)
|
OT393IMA
|
TCF21_HUMAN
|
Decreases Expression
|
[18] |
ER lumen protein-retaining receptor 3 (KDELR3)
|
OTW8C1V0
|
ERD23_HUMAN
|
Decreases Expression
|
[18] |
Adhesion G protein-coupled receptor B3 (ADGRB3)
|
OT1EWGRW
|
AGRB3_HUMAN
|
Increases Expression
|
[18] |
Protocadherin-7 (PCDH7)
|
OTP091X8
|
PCDH7_HUMAN
|
Decreases Expression
|
[18] |
Suppression of tumorigenicity 18 protein (ST18)
|
OTPRIMTA
|
ST18_HUMAN
|
Increases Expression
|
[18] |
TBC1 domain family member 4 (TBC1D4)
|
OTK66C40
|
TBCD4_HUMAN
|
Decreases Expression
|
[18] |
Protein-tyrosine sulfotransferase 1 (TPST1)
|
OTDPQKEA
|
TPST1_HUMAN
|
Decreases Expression
|
[18] |
Clathrin coat assembly protein AP180 (SNAP91)
|
OTE3EXWZ
|
AP180_HUMAN
|
Increases Expression
|
[18] |
Kelch-like protein 41 (KLHL41)
|
OTLABE56
|
KLH41_HUMAN
|
Decreases Expression
|
[18] |
Perilipin-3 (PLIN3)
|
OT9ZA7MR
|
PLIN3_HUMAN
|
Decreases Expression
|
[18] |
P antigen family member 4 (PAGE4)
|
OT2VLWT0
|
PAGE4_HUMAN
|
Decreases Expression
|
[18] |
Receptor activity-modifying protein 1 (RAMP1)
|
OT7UT2XB
|
RAMP1_HUMAN
|
Decreases Expression
|
[18] |
Phosphatase and actin regulator 2 (PHACTR2)
|
OTWMX2A8
|
PHAR2_HUMAN
|
Decreases Expression
|
[18] |
Leucine-rich repeat neuronal protein 2 (LRRN2)
|
OTGP2DCY
|
LRRN2_HUMAN
|
Decreases Expression
|
[18] |
Cartilage-associated protein (CRTAP)
|
OT53H5U6
|
CRTAP_HUMAN
|
Decreases Expression
|
[18] |
Breast cancer anti-estrogen resistance protein 3 (BCAR3)
|
OTPJ17M8
|
BCAR3_HUMAN
|
Decreases Expression
|
[18] |
Matrix metalloproteinase-23 (MMP23B)
|
OT2OR6TS
|
MMP23_HUMAN
|
Decreases Expression
|
[18] |
Regulator of G-protein signaling 20 (RGS20)
|
OT6CGYHW
|
RGS20_HUMAN
|
Increases Expression
|
[18] |
Lymphocyte antigen 6H (LY6H)
|
OTTFGUD2
|
LY6H_HUMAN
|
Decreases Expression
|
[18] |
Slit homolog 2 protein (SLIT2)
|
OTLS2RJ4
|
SLIT2_HUMAN
|
Decreases Expression
|
[18] |
Sorbin and SH3 domain-containing protein 2 (SORBS2)
|
OTJSX44Y
|
SRBS2_HUMAN
|
Increases Expression
|
[18] |
Glutaminase kidney isoform, mitochondrial (GLS)
|
OTGOZG2M
|
GLSK_HUMAN
|
Decreases Expression
|
[18] |
SLIT and NTRK-like protein 3 (SLITRK3)
|
OT018P93
|
SLIK3_HUMAN
|
Decreases Expression
|
[18] |
Myelin protein zero-like protein 1 (MPZL1)
|
OTJSUUHR
|
MPZL1_HUMAN
|
Decreases Expression
|
[18] |
BAG family molecular chaperone regulator 3 (BAG3)
|
OTVXYUDQ
|
BAG3_HUMAN
|
Decreases Expression
|
[18] |
EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2)
|
OT0I2B4J
|
FBLN4_HUMAN
|
Decreases Expression
|
[18] |
Heart- and neural crest derivatives-expressed protein 1 (HAND1)
|
OTN4IPVV
|
HAND1_HUMAN
|
Decreases Expression
|
[18] |
G1/S-specific cyclin-E2 (CCNE2)
|
OTBBUKQQ
|
CCNE2_HUMAN
|
Increases Expression
|
[18] |
Cytochrome b5 (CYB5A)
|
OT6SN4RM
|
CYB5_HUMAN
|
Decreases Expression
|
[18] |
Tissue-type plasminogen activator (PLAT)
|
OTQPDNAB
|
TPA_HUMAN
|
Decreases Expression
|
[18] |
Serine protease inhibitor Kazal-type 1 (SPINK1)
|
OTSUVAL2
|
ISK1_HUMAN
|
Increases Expression
|
[18] |
Metalloproteinase inhibitor 1 (TIMP1)
|
OTOXC51H
|
TIMP1_HUMAN
|
Decreases Expression
|
[18] |
Pro-neuropeptide Y (NPY)
|
OT4ICV3P
|
NPY_HUMAN
|
Decreases Expression
|
[18] |
Collagen alpha-1(I) chain (COL1A1)
|
OTI31178
|
CO1A1_HUMAN
|
Decreases Expression
|
[18] |
Collagen alpha-1(III) chain (COL3A1)
|
OTT1EMLM
|
CO3A1_HUMAN
|
Decreases Expression
|
[18] |
Alpha-crystallin B chain (CRYAB)
|
OTY4JGYU
|
CRYAB_HUMAN
|
Decreases Expression
|
[18] |
Metallothionein-2 (MT2A)
|
OTHOACHD
|
MT2_HUMAN
|
Decreases Expression
|
[18] |
Metallothionein-1A (MT1A)
|
OTKBH52X
|
MT1A_HUMAN
|
Decreases Expression
|
[18] |
Metallothionein-1E (MT1E)
|
OTXJKU4Y
|
MT1E_HUMAN
|
Decreases Expression
|
[18] |
Sodium/potassium-transporting ATPase subunit beta-1 (ATP1B1)
|
OTTO6ZP4
|
AT1B1_HUMAN
|
Decreases Expression
|
[18] |
Keratin, type II cytoskeletal 8 (KRT8)
|
OTTM4X11
|
K2C8_HUMAN
|
Decreases Expression
|
[18] |
Collagen alpha-2(V) chain (COL5A2)
|
OT5VOSQE
|
CO5A2_HUMAN
|
Decreases Expression
|
[18] |
Tyrosine-protein kinase Fyn (FYN)
|
OTLSLVZS
|
FYN_HUMAN
|
Increases Expression
|
[18] |
Tyrosine 3-monooxygenase (TH)
|
OT6ZORKP
|
TY3H_HUMAN
|
Decreases Expression
|
[18] |
Annexin A2 (ANXA2)
|
OTFNS0CC
|
ANXA2_HUMAN
|
Decreases Expression
|
[18] |
Calpain-1 catalytic subunit (CAPN1)
|
OTK6OQZR
|
CAN1_HUMAN
|
Decreases Expression
|
[18] |
Decorin (DCN)
|
OTWLJL7K
|
PGS2_HUMAN
|
Decreases Expression
|
[18] |
Procathepsin L (CTSL)
|
OTYTUW29
|
CATL1_HUMAN
|
Decreases Expression
|
[18] |
Tyrosine-protein kinase Lyn (LYN)
|
OTP686K2
|
LYN_HUMAN
|
Decreases Expression
|
[18] |
Thrombospondin-1 (THBS1)
|
OT0ECWK3
|
TSP1_HUMAN
|
Increases Expression
|
[18] |
Collagen alpha-2(I) chain (COL1A2)
|
OTY7G382
|
CO1A2_HUMAN
|
Decreases Expression
|
[18] |
Annexin A6 (ANXA6)
|
OT9KIQ0Y
|
ANXA6_HUMAN
|
Decreases Expression
|
[18] |
Rho-related GTP-binding protein RhoC (RHOC)
|
OTOLE1FT
|
RHOC_HUMAN
|
Decreases Expression
|
[18] |
Matrix Gla protein (MGP)
|
OTZWU3FU
|
MGP_HUMAN
|
Decreases Expression
|
[18] |
Keratin, type I cytoskeletal 19 (KRT19)
|
OTDGDQ75
|
K1C19_HUMAN
|
Decreases Expression
|
[18] |
SPARC (SPARC)
|
OTPN90H0
|
SPRC_HUMAN
|
Decreases Expression
|
[18] |
Platelet-derived growth factor receptor beta (PDGFRB)
|
OTYSNK9Q
|
PGFRB_HUMAN
|
Decreases Expression
|
[18] |
Homeobox protein Hox-C6 (HOXC6)
|
OTBCRAZV
|
HXC6_HUMAN
|
Decreases Expression
|
[18] |
Pro-cathepsin H (CTSH)
|
OTLFL0DG
|
CATH_HUMAN
|
Decreases Expression
|
[18] |
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1)
|
OTXOQDSG
|
IFIT1_HUMAN
|
Decreases Expression
|
[18] |
Thymosin beta-15A (TMSB15A)
|
OTSBWCES
|
TB15A_HUMAN
|
Increases Expression
|
[18] |
Ras-related protein R-Ras (RRAS)
|
OTBBF28C
|
RRAS_HUMAN
|
Decreases Expression
|
[18] |
Tissue factor pathway inhibitor (TFPI)
|
OTA0FX16
|
TFPI1_HUMAN
|
Decreases Expression
|
[18] |
Growth hormone receptor (GHR)
|
OT8WUWMU
|
GHR_HUMAN
|
Decreases Expression
|
[18] |
Hyaluronan and proteoglycan link protein 1 (HAPLN1)
|
OTXWR9TJ
|
HPLN1_HUMAN
|
Decreases Expression
|
[18] |
Microtubule-associated protein 2 (MAP2)
|
OT6UYT3X
|
MTAP2_HUMAN
|
Increases Expression
|
[18] |
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1)
|
OTA675TJ
|
GTR1_HUMAN
|
Decreases Expression
|
[18] |
Collagen alpha-2(VI) chain (COL6A2)
|
OTQC6PPO
|
CO6A2_HUMAN
|
Decreases Expression
|
[18] |
Collagen alpha-3(VI) chain (COL6A3)
|
OTAS6R6I
|
CO6A3_HUMAN
|
Decreases Expression
|
[18] |
Creatine kinase B-type (CKB)
|
OTUCKOTT
|
KCRB_HUMAN
|
Increases Expression
|
[18] |
Bone morphogenetic protein 4 (BMP4)
|
OTPZMDFH
|
BMP4_HUMAN
|
Decreases Expression
|
[18] |
Myosin light chain 4 (MYL4)
|
OTURFCSE
|
MYL4_HUMAN
|
Decreases Expression
|
[18] |
Cytochrome b-245 light chain (CYBA)
|
OT16N9ZO
|
CY24A_HUMAN
|
Decreases Expression
|
[18] |
Elongation factor 2 (EEF2)
|
OTZ7SZ39
|
EF2_HUMAN
|
Decreases Expression
|
[18] |
Annexin A8 (ANXA8)
|
OTLSSQCY
|
ANXA8_HUMAN
|
Decreases Expression
|
[18] |
Beta-enolase (ENO3)
|
OT3HYKYI
|
ENOB_HUMAN
|
Decreases Expression
|
[18] |
Ezrin (EZR)
|
OTHBPF1Z
|
EZRI_HUMAN
|
Decreases Expression
|
[18] |
N-chimaerin (CHN1)
|
OTM196M3
|
CHIN_HUMAN
|
Decreases Expression
|
[18] |
CD44 antigen (CD44)
|
OT9TTJ41
|
CD44_HUMAN
|
Decreases Expression
|
[18] |
Histone H1.2 (H1-2)
|
OT0AVI4M
|
H12_HUMAN
|
Decreases Expression
|
[18] |
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (GNB3)
|
OTA6HYBA
|
GBB3_HUMAN
|
Decreases Expression
|
[18] |
Natriuretic peptides B (NPPB)
|
OTSN2IPY
|
ANFB_HUMAN
|
Increases Expression
|
[18] |
Homeobox protein Hox-B8 (HOXB8)
|
OTKHOD17
|
HXB8_HUMAN
|
Decreases Expression
|
[18] |
Homeobox protein Hox-B4 (HOXB4)
|
OTH1HRW5
|
HXB4_HUMAN
|
Decreases Expression
|
[18] |
Homeobox protein Hox-B6 (HOXB6)
|
OT3TFQ0U
|
HXB6_HUMAN
|
Decreases Expression
|
[18] |
Neuromodulin (GAP43)
|
OT2OTGGV
|
NEUM_HUMAN
|
Increases Expression
|
[18] |
Insulin-like growth factor-binding protein 3 (IGFBP3)
|
OTIX63TX
|
IBP3_HUMAN
|
Decreases Expression
|
[18] |
Integrin beta-5 (ITGB5)
|
OT21MF51
|
ITB5_HUMAN
|
Decreases Expression
|
[18] |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3)
|
OTC1UOHP
|
ATF3_HUMAN
|
Decreases Expression
|
[18] |
Protachykinin-1 (TAC1)
|
OTM842YW
|
TKN1_HUMAN
|
Increases Expression
|
[18] |
Homeobox protein Hox-A5 (HOXA5)
|
OTLWGPQD
|
HXA5_HUMAN
|
Increases Expression
|
[18] |
Ephrin-A1 (EFNA1)
|
OTU2NUA2
|
EFNA1_HUMAN
|
Decreases Expression
|
[18] |
Collagen alpha-1(IX) chain (COL9A1)
|
OTWBR27Y
|
CO9A1_HUMAN
|
Increases Expression
|
[18] |
Collagen alpha-1(V) chain (COL5A1)
|
OT24078H
|
CO5A1_HUMAN
|
Decreases Expression
|
[18] |
Cannabinoid receptor 1 (CNR1)
|
OTEALO6G
|
CNR1_HUMAN
|
Increases Expression
|
[18] |
Tumor necrosis factor alpha-induced protein 3 (TNFAIP3)
|
OTVLI4DD
|
TNAP3_HUMAN
|
Decreases Expression
|
[18] |
Midkine (MDK)
|
OTF24HKC
|
MK_HUMAN
|
Decreases Expression
|
[18] |
Bone morphogenetic protein 5 (BMP5)
|
OTC0Y6E0
|
BMP5_HUMAN
|
Decreases Expression
|
[18] |
Cadherin-3 (CDH3)
|
OTKNLQU7
|
CADH3_HUMAN
|
Decreases Expression
|
[18] |
Calretinin (CALB2)
|
OTSNMCG9
|
CALB2_HUMAN
|
Decreases Expression
|
[18] |
Fibulin-1 (FBLN1)
|
OT5MHHOP
|
FBLN1_HUMAN
|
Decreases Expression
|
[18] |
Receptor-type tyrosine-protein phosphatase zeta (PTPRZ1)
|
OT2NRISU
|
PTPRZ_HUMAN
|
Increases Expression
|
[18] |
Insulin-like growth factor-binding protein 5 (IGFBP5)
|
OTRE5V0C
|
IBP5_HUMAN
|
Decreases Expression
|
[18] |
Paired box protein Pax-6 (PAX6)
|
OTOC9876
|
PAX6_HUMAN
|
Increases Expression
|
[18] |
Protein S100-A4 (S100A4)
|
OTLRGFSQ
|
S10A4_HUMAN
|
Decreases Expression
|
[18] |
Ciliary neurotrophic factor receptor subunit alpha (CNTFR)
|
OT3B1RGG
|
CNTFR_HUMAN
|
Increases Expression
|
[18] |
Stomatin (STOM)
|
OTC8R6EH
|
STOM_HUMAN
|
Decreases Expression
|
[18] |
Protein-lysine 6-oxidase (LOX)
|
OT1C2HIU
|
LYOX_HUMAN
|
Decreases Expression
|
[18] |
Homeobox protein MSX-1 (MSX1)
|
OT5U41ZP
|
MSX1_HUMAN
|
Decreases Expression
|
[18] |
Grancalcin (GCA)
|
OTAJ7ZHG
|
GRAN_HUMAN
|
Decreases Expression
|
[18] |
Cellular retinoic acid-binding protein 1 (CRABP1)
|
OTISDG5X
|
RABP1_HUMAN
|
Increases Expression
|
[18] |
Aquaporin-1 (AQP1)
|
OTX5MYX9
|
AQP1_HUMAN
|
Decreases Expression
|
[18] |
G1/S-specific cyclin-D3 (CCND3)
|
OTNKPQ22
|
CCND3_HUMAN
|
Decreases Expression
|
[18] |
Tyrosine-protein kinase receptor UFO (AXL)
|
OTKA2SUX
|
UFO_HUMAN
|
Decreases Expression
|
[18] |
Translocator protein (TSPO)
|
OTSU7ESK
|
TSPO_HUMAN
|
Decreases Expression
|
[18] |
Gastrin-releasing peptide receptor (GRPR)
|
OTBQGYJT
|
GRPR_HUMAN
|
Decreases Expression
|
[18] |
Homeobox protein Hox-C8 (HOXC8)
|
OTJUYU8J
|
HXC8_HUMAN
|
Decreases Expression
|
[18] |
Syndecan-4 (SDC4)
|
OTKUVUGZ
|
SDC4_HUMAN
|
Decreases Expression
|
[18] |
Dimethylaniline monooxygenase 4 (FMO4)
|
OT5UYZL7
|
FMO4_HUMAN
|
Decreases Expression
|
[18] |
Gastrin/cholecystokinin type B receptor (CCKBR)
|
OTQSNXOI
|
GASR_HUMAN
|
Decreases Expression
|
[18] |
Serpin B6 (SERPINB6)
|
OT7G55IK
|
SPB6_HUMAN
|
Decreases Expression
|
[18] |
Apelin receptor (APLNR)
|
OT8585HU
|
APJ_HUMAN
|
Decreases Expression
|
[18] |
Copper-transporting ATPase 2 (ATP7B)
|
OTPWLNCO
|
ATP7B_HUMAN
|
Decreases Expression
|
[18] |
Collagen alpha-1(XVIII) chain (COL18A1)
|
OTJFUH6O
|
COIA1_HUMAN
|
Decreases Expression
|
[18] |
Melanocyte protein PMEL (PMEL)
|
OTCDDHHM
|
PMEL_HUMAN
|
Increases Expression
|
[18] |
Peripherin (PRPH)
|
OT6VUH78
|
PERI_HUMAN
|
Decreases Expression
|
[18] |
Transcription factor SOX-3 (SOX3)
|
OT1CRCOB
|
SOX3_HUMAN
|
Increases Expression
|
[18] |
Glutamate receptor 2 (GRIA2)
|
OT5N1WB7
|
GRIA2_HUMAN
|
Increases Expression
|
[18] |
Troponin T, cardiac muscle (TNNT2)
|
OT80NN7R
|
TNNT2_HUMAN
|
Decreases Expression
|
[18] |
Peptidyl-prolyl cis-trans isomerase C (PPIC)
|
OTY5Q42N
|
PPIC_HUMAN
|
Decreases Expression
|
[18] |
Leptin receptor (LEPR)
|
OT9H7G0C
|
LEPR_HUMAN
|
Decreases Expression
|
[18] |
Neuromedin-U (NMU)
|
OTW9X7BQ
|
NMU_HUMAN
|
Increases Expression
|
[18] |
Nestin (NES)
|
OTZ9PZ14
|
NEST_HUMAN
|
Increases Expression
|
[18] |
Casein kinase I isoform delta (CSNK1D)
|
OTNF4S77
|
KC1D_HUMAN
|
Decreases Expression
|
[18] |
CCAAT/enhancer-binding protein delta (CEBPD)
|
OTNBIPMY
|
CEBPD_HUMAN
|
Decreases Expression
|
[18] |
Regulator of G-protein signaling 4 (RGS4)
|
OTG94HHL
|
RGS4_HUMAN
|
Decreases Expression
|
[18] |
Cyclin-dependent kinase inhibitor 1C (CDKN1C)
|
OTASTJ3Q
|
CDN1C_HUMAN
|
Decreases Expression
|
[18] |
Serpin B9 (SERPINB9)
|
OTJ811IF
|
SPB9_HUMAN
|
Decreases Expression
|
[18] |
Serpin H1 (SERPINH1)
|
OTKGI7BS
|
SERPH_HUMAN
|
Decreases Expression
|
[18] |
Ras association domain-containing protein 2 (RASSF2)
|
OT2JHDO4
|
RASF2_HUMAN
|
Increases Expression
|
[18] |
Lipopolysaccharide-responsive and beige-like anchor protein (LRBA)
|
OTOUZN9G
|
LRBA_HUMAN
|
Decreases Expression
|
[18] |
RNA-binding protein Nova-1 (NOVA1)
|
OT6A9KHY
|
NOVA1_HUMAN
|
Increases Expression
|
[18] |
Neuronal membrane glycoprotein M6-a (GPM6A)
|
OT8G13EG
|
GPM6A_HUMAN
|
Increases Expression
|
[18] |
Lumican (LUM)
|
OTSRC874
|
LUM_HUMAN
|
Decreases Expression
|
[18] |
Heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3)
|
OT4O4NFS
|
ROA3_HUMAN
|
Decreases Expression
|
[18] |
Rho GDP-dissociation inhibitor 2 (ARHGDIB)
|
OT9PD6CS
|
GDIR2_HUMAN
|
Decreases Expression
|
[18] |
Cationic amino acid transporter 2 (SLC7A2)
|
OTAMWBVM
|
CTR2_HUMAN
|
Decreases Expression
|
[18] |
Atrophin-1 (ATN1)
|
OTNZFLKY
|
ATN1_HUMAN
|
Increases Expression
|
[18] |
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (PDE1A)
|
OTU7J3F7
|
PDE1A_HUMAN
|
Increases Expression
|
[18] |
Hydroxymethylglutaryl-CoA synthase, mitochondrial (HMGCS2)
|
OTC3RUN9
|
HMCS2_HUMAN
|
Decreases Expression
|
[18] |
Phospholipid transfer protein (PLTP)
|
OTVJJO5Z
|
PLTP_HUMAN
|
Decreases Expression
|
[18] |
Microfibril-associated glycoprotein 4 (MFAP4)
|
OT5W64QY
|
MFAP4_HUMAN
|
Decreases Expression
|
[18] |
Cadherin-11 (CDH11)
|
OTIZKPTF
|
CAD11_HUMAN
|
Decreases Expression
|
[18] |
Claudin-15 (CLDN15)
|
OT9K0KI7
|
CLD15_HUMAN
|
Decreases Expression
|
[18] |
Junctional adhesion molecule B (JAM2)
|
OTHVJJRJ
|
JAM2_HUMAN
|
Increases Expression
|
[18] |
Myelin proteolipid protein (PLP1)
|
OT8CM9CX
|
MYPR_HUMAN
|
Increases Expression
|
[18] |
Protein S100-A10 (S100A10)
|
OTI71243
|
S10AA_HUMAN
|
Decreases Expression
|
[18] |
Heart- and neural crest derivatives-expressed protein 2 (HAND2)
|
OTCXYW4Y
|
HAND2_HUMAN
|
Decreases Expression
|
[18] |
Neurocalcin-delta (NCALD)
|
OTJZ8UEL
|
NCALD_HUMAN
|
Increases Expression
|
[18] |
cAMP-dependent protein kinase inhibitor alpha (PKIA)
|
OT8M5GVO
|
IPKA_HUMAN
|
Decreases Expression
|
[18] |
Actin, alpha cardiac muscle 1 (ACTC1)
|
OTJU04B1
|
ACTC_HUMAN
|
Decreases Expression
|
[18] |
Actin, alpha skeletal muscle (ACTA1)
|
OTOVGLPG
|
ACTS_HUMAN
|
Increases Expression
|
[18] |
Pituitary homeobox 1 (PITX1)
|
OTA0UN4C
|
PITX1_HUMAN
|
Decreases Expression
|
[18] |
Oxidized low-density lipoprotein receptor 1 (OLR1)
|
OTS44RIC
|
OLR1_HUMAN
|
Decreases Expression
|
[18] |
Iroquois-class homeodomain protein IRX-5 (IRX5)
|
OT05J514
|
IRX5_HUMAN
|
Increases Expression
|
[18] |
Reelin (RELN)
|
OTLKMW1O
|
RELN_HUMAN
|
Decreases Expression
|
[18] |
Arginase-2, mitochondrial (ARG2)
|
OTCPI0E8
|
ARGI2_HUMAN
|
Decreases Expression
|
[18] |
Metallothionein-1X (MT1X)
|
OT9AKFVS
|
MT1X_HUMAN
|
Decreases Expression
|
[18] |
Matrix-remodeling-associated protein 7 (MXRA7)
|
OTVQLYIY
|
MXRA7_HUMAN
|
Decreases Expression
|
[18] |
Disabled homolog 2 (DAB2)
|
OTRMQTMZ
|
DAB2_HUMAN
|
Decreases Expression
|
[18] |
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (PDE1B)
|
OT9NPJCR
|
PDE1B_HUMAN
|
Increases Expression
|
[18] |
Myosin regulatory light chain 2, atrial isoform (MYL7)
|
OT7ZNDP4
|
MLRA_HUMAN
|
Decreases Expression
|
[18] |
Peripheral myelin protein 22 (PMP22)
|
OTXWYWCZ
|
PMP22_HUMAN
|
Decreases Expression
|
[18] |
Flavin-containing monooxygenase 1 (FMO1)
|
OTTHSQKP
|
FMO1_HUMAN
|
Decreases Expression
|
[18] |
ATP-dependent 6-phosphofructokinase, platelet type (PFKP)
|
OTFP7AA8
|
PFKAP_HUMAN
|
Decreases Expression
|
[18] |
Zinc finger protein basonuclin-1 (BNC1)
|
OTGJ5WUF
|
BNC1_HUMAN
|
Decreases Expression
|
[18] |
Transgelin (TAGLN)
|
OTAEZ0KP
|
TAGL_HUMAN
|
Increases Expression
|
[18] |
Guanylate cyclase soluble subunit alpha-1 (GUCY1A1)
|
OTPTCBUN
|
GCYA1_HUMAN
|
Decreases Expression
|
[18] |
Sterol 26-hydroxylase, mitochondrial (CYP27A1)
|
OT649C01
|
CP27A_HUMAN
|
Decreases Expression
|
[18] |
Desmocollin-2 (DSC2)
|
OTODVH8K
|
DSC2_HUMAN
|
Decreases Expression
|
[18] |
Angiopoietin-1 receptor (TEK)
|
OT78YN57
|
TIE2_HUMAN
|
Decreases Expression
|
[18] |
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1)
|
OT3ZIANF
|
PLOD1_HUMAN
|
Decreases Expression
|
[18] |
Transforming growth factor beta receptor type 3 (TGFBR3)
|
OTQOOUC4
|
TGBR3_HUMAN
|
Decreases Expression
|
[18] |
Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R)
|
OTQF5ZAK
|
PTH1R_HUMAN
|
Decreases Expression
|
[18] |
MBT domain-containing protein 1 (MBTD1)
|
OT2P6943
|
MBTD1_HUMAN
|
Increases Expression
|
[18] |
3',5'-cyclic-AMP phosphodiesterase 4B (PDE4B)
|
OTOA8WU2
|
PDE4B_HUMAN
|
Increases Expression
|
[18] |
Trefoil factor 3 (TFF3)
|
OTJJDRTU
|
TFF3_HUMAN
|
Increases Expression
|
[18] |
Regulator of G-protein signaling 1 (RGS1)
|
OTGXJYMG
|
RGS1_HUMAN
|
Decreases Expression
|
[18] |
Neuroblast differentiation-associated protein AHNAK (AHNAK)
|
OT6KH1WG
|
AHNK_HUMAN
|
Decreases Expression
|
[18] |
Coiled-coil domain-containing protein 15 (CCDC15)
|
OT1NZX84
|
CCD15_HUMAN
|
Increases Expression
|
[18] |
Transmembrane protein 62 (TMEM62)
|
OTJ4SPCM
|
TMM62_HUMAN
|
Increases Expression
|
[18] |
Bone marrow stromal antigen 2 (BST2)
|
OTU4LCJV
|
BST2_HUMAN
|
Decreases Expression
|
[18] |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3GAL1)
|
OTFCO8QX
|
SIA4A_HUMAN
|
Decreases Expression
|
[18] |
Tyrosine-protein kinase Mer (MERTK)
|
OTWBRAJ6
|
MERTK_HUMAN
|
Decreases Expression
|
[18] |
Transmembrane emp24 domain-containing protein 1 (TMED1)
|
OTWSH0J8
|
TMED1_HUMAN
|
Decreases Expression
|
[18] |
Filamin-C (FLNC)
|
OT3F8J6Y
|
FLNC_HUMAN
|
Decreases Expression
|
[18] |
Transforming growth factor beta activator LRRC32 (LRRC32)
|
OTG7EDZL
|
LRC32_HUMAN
|
Decreases Expression
|
[18] |
Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH)
|
OTMCFF0K
|
PIGH_HUMAN
|
Decreases Expression
|
[18] |
Desmocollin-3 (DSC3)
|
OTYG47F8
|
DSC3_HUMAN
|
Decreases Expression
|
[18] |
Eukaryotic translation initiation factor 4H (EIF4H)
|
OTGZI072
|
IF4H_HUMAN
|
Decreases Expression
|
[18] |
Periostin (POSTN)
|
OTWP62UA
|
POSTN_HUMAN
|
Decreases Expression
|
[18] |
Phosphoglucomutase-like protein 5 (PGM5)
|
OTEAS7OC
|
PGM5_HUMAN
|
Decreases Expression
|
[18] |
Nicotinate-nucleotide pyrophosphorylase (QPRT)
|
OT6SKKLL
|
NADC_HUMAN
|
Decreases Expression
|
[18] |
Leucine-rich repeat-containing protein 41 (LRRC41)
|
OT4YSBV5
|
LRC41_HUMAN
|
Decreases Expression
|
[18] |
Delta(24)-sterol reductase (DHCR24)
|
OTP301JW
|
DHC24_HUMAN
|
Decreases Expression
|
[18] |
Probable G-protein coupled receptor 19 (GPR19)
|
OTR7MUS5
|
GPR19_HUMAN
|
Increases Expression
|
[18] |
Alpha-internexin (INA)
|
OT1D33T4
|
AINX_HUMAN
|
Increases Expression
|
[18] |
Kynureninase (KYNU)
|
OTINL2RE
|
KYNU_HUMAN
|
Decreases Expression
|
[18] |
Thiosulfate sulfurtransferase (TST)
|
OTZ4F5LK
|
THTR_HUMAN
|
Decreases Expression
|
[18] |
Reticulon-1 (RTN1)
|
OTCX1SMK
|
RTN1_HUMAN
|
Increases Expression
|
[18] |
Discoidin domain-containing receptor 2 (DDR2)
|
OT9IHOGZ
|
DDR2_HUMAN
|
Decreases Expression
|
[18] |
Rho GTPase-activating protein 44 (ARHGAP44)
|
OTHJUCO1
|
RHG44_HUMAN
|
Decreases Expression
|
[18] |
Sodium-coupled monocarboxylate transporter 2 (SLC5A12)
|
OTKY9NAL
|
SC5AC_HUMAN
|
Decreases Expression
|
[18] |
Keratin, type I cytoskeletal 24 (KRT24)
|
OTR7MT1E
|
K1C24_HUMAN
|
Decreases Expression
|
[18] |
Electroneutral sodium bicarbonate exchanger 1 (SLC4A8)
|
OTKJ0X6Q
|
S4A8_HUMAN
|
Decreases Expression
|
[18] |
HLA class II histocompatibility antigen, DR beta 5 chain (HLA-DRB5)
|
OTUX5TWM
|
DRB5_HUMAN
|
Decreases Expression
|
[18] |
Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (MINDY4)
|
OTBZ2SZB
|
MINY4_HUMAN
|
Decreases Expression
|
[18] |
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 (PLCH1)
|
OT6Z1L2E
|
PLCH1_HUMAN
|
Increases Expression
|
[18] |
Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (SVEP1)
|
OTOBICRD
|
SVEP1_HUMAN
|
Decreases Expression
|
[18] |
PDZ and LIM domain protein 3 (PDLIM3)
|
OTVXQC81
|
PDLI3_HUMAN
|
Increases Expression
|
[18] |
Protein LBH (LBH)
|
OT87AT1X
|
LBH_HUMAN
|
Decreases Expression
|
[18] |
Cordon-bleu protein-like 1 (COBLL1)
|
OTQFN1TC
|
COBL1_HUMAN
|
Decreases Expression
|
[18] |
Spindlin-4 (SPIN4)
|
OT09ZWHM
|
SPIN4_HUMAN
|
Decreases Expression
|
[18] |
Trans-2,3-enoyl-CoA reductase-like (TECRL)
|
OTXLSNCP
|
TECRL_HUMAN
|
Decreases Expression
|
[18] |
Placenta-specific protein 9 (PLAC9)
|
OTZHIJ44
|
PLAC9_HUMAN
|
Decreases Expression
|
[18] |
Collectin-12 (COLEC12)
|
OTIQTK9G
|
COL12_HUMAN
|
Decreases Expression
|
[18] |
CUGBP Elav-like family member 3 (CELF3)
|
OTTP45WK
|
CELF3_HUMAN
|
Increases Expression
|
[18] |
KN motif and ankyrin repeat domain-containing protein 4 (KANK4)
|
OT5WC0Q8
|
KANK4_HUMAN
|
Decreases Expression
|
[18] |
Transcription factor HES-5 (HES5)
|
OTW7JEHV
|
HES5_HUMAN
|
Increases Expression
|
[18] |
Collagen alpha-1(XIII) chain (COL13A1)
|
OTM9IM6J
|
CODA1_HUMAN
|
Decreases Expression
|
[18] |
Terminal nucleotidyltransferase 5C (TENT5C)
|
OTOWVQ4O
|
TET5C_HUMAN
|
Decreases Expression
|
[18] |
FYN-binding protein 2 (FYB2)
|
OTA3NG8M
|
FYB2_HUMAN
|
Decreases Expression
|
[18] |
F-actin-uncapping protein LRRC16A (CARMIL1)
|
OT1A5IX5
|
CARL1_HUMAN
|
Decreases Expression
|
[18] |
Pikachurin (EGFLAM)
|
OTACZZJ0
|
EGFLA_HUMAN
|
Decreases Expression
|
[18] |
Carboxypeptidase Z (CPZ)
|
OT5HUR28
|
CBPZ_HUMAN
|
Decreases Expression
|
[18] |
NADH-cytochrome b5 reductase 2 (CYB5R2)
|
OTTLM7XN
|
NB5R2_HUMAN
|
Decreases Expression
|
[18] |
Repulsive guidance molecule B (RGMB)
|
OT2DROYU
|
RGMB_HUMAN
|
Increases Expression
|
[18] |
Caveolae-associated protein 1 (CAVIN1)
|
OTFO915U
|
CAVN1_HUMAN
|
Decreases Expression
|
[18] |
Cdc42 effector protein 5 (CDC42EP5)
|
OTQQDUCD
|
BORG3_HUMAN
|
Decreases Expression
|
[18] |
Cytochrome b5 domain-containing protein 1 (CYB5D1)
|
OTSZWTPT
|
CB5D1_HUMAN
|
Decreases Expression
|
[18] |
Transmembrane protein 88 (TMEM88)
|
OTA96YEL
|
TMM88_HUMAN
|
Decreases Expression
|
[18] |
Protein cornichon homolog 2 (CNIH2)
|
OTT2ECCW
|
CNIH2_HUMAN
|
Increases Expression
|
[18] |
Prostate androgen-regulated mucin-like protein 1 (PARM1)
|
OTDNK7EX
|
PARM1_HUMAN
|
Decreases Expression
|
[18] |
Inactive serine protease PAMR1 (PAMR1)
|
OT83ZH5U
|
PAMR1_HUMAN
|
Decreases Expression
|
[18] |
R-spondin-2 (RSPO2)
|
OT3HHXU0
|
RSPO2_HUMAN
|
Decreases Expression
|
[18] |
Zinc finger protein basonuclin-2 (BNC2)
|
OTU22H9Z
|
BNC2_HUMAN
|
Decreases Expression
|
[18] |
Staphylococcal nuclease domain-containing protein 1 (SND1)
|
OTT734JN
|
SND1_HUMAN
|
Decreases Expression
|
[18] |
Monocarboxylate transporter 9 (SLC16A9)
|
OTVCLKQQ
|
MOT9_HUMAN
|
Increases Expression
|
[18] |
Centriolin (CNTRL)
|
OTQI3VBA
|
CNTRL_HUMAN
|
Increases Expression
|
[18] |
Calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1)
|
OTKCR5XL
|
CK2N1_HUMAN
|
Increases Expression
|
[18] |
Schlafen family member 11 (SLFN11)
|
OTJWFPMY
|
SLN11_HUMAN
|
Increases Expression
|
[18] |
Polypeptide N-acetylgalactosaminyltransferase 10 (GALNT10)
|
OTZ6FDOL
|
GLT10_HUMAN
|
Decreases Expression
|
[18] |
Alpha-protein kinase 2 (ALPK2)
|
OTWZZDQ9
|
ALPK2_HUMAN
|
Decreases Expression
|
[18] |
E3 ubiquitin-protein ligase MARCHF3 (MARCHF3)
|
OT89V4N5
|
MARH3_HUMAN
|
Decreases Expression
|
[18] |
Transmembrane protein 200A (TMEM200A)
|
OTVJZIOR
|
T200A_HUMAN
|
Decreases Expression
|
[18] |
Podoplanin (PDPN)
|
OTBUV19I
|
PDPN_HUMAN
|
Decreases Expression
|
[18] |
Rhophilin-2 (RHPN2)
|
OTTYWMF6
|
RHPN2_HUMAN
|
Decreases Expression
|
[18] |
Epidermal growth factor-like protein 6 (EGFL6)
|
OT331X59
|
EGFL6_HUMAN
|
Decreases Expression
|
[18] |
5'-3' exonuclease PLD3 (PLD3)
|
OTL07SP2
|
PLD3_HUMAN
|
Decreases Expression
|
[18] |
Neuron navigator 2 (NAV2)
|
OTGAOL01
|
NAV2_HUMAN
|
Decreases Expression
|
[18] |
Somatomedin-B and thrombospondin type-1 domain-containing protein (SBSPON)
|
OTBHAW5K
|
SBSPO_HUMAN
|
Decreases Expression
|
[18] |
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (GCNT2)
|
OTRUIMC4
|
GNT2A_HUMAN
|
Decreases Expression
|
[18] |
Sperm-associated antigen 16 protein (SPAG16)
|
OTIFUPYD
|
SPG16_HUMAN
|
Increases Expression
|
[18] |
Cytochrome P450 4X1 (CYP4X1)
|
OTMTEUNE
|
CP4X1_HUMAN
|
Decreases Expression
|
[18] |
Inactive serine protease 35 (PRSS35)
|
OT09H6WH
|
PRS35_HUMAN
|
Decreases Expression
|
[18] |
Secreted frizzled-related protein 1 (SFRP1)
|
OT0U9G41
|
SFRP1_HUMAN
|
Increases Expression
|
[18] |
Reprimo-like protein (RPRML)
|
OTPOESFN
|
RPRML_HUMAN
|
Increases Expression
|
[18] |
Actin filament-associated protein 1-like 2 (AFAP1L2)
|
OTJBI0VN
|
AF1L2_HUMAN
|
Decreases Expression
|
[18] |
Protocadherin-20 (PCDH20)
|
OTFSNRXK
|
PCD20_HUMAN
|
Decreases Expression
|
[18] |
Fibrous sheath-interacting protein 1 (FSIP1)
|
OTYLL6GM
|
FSIP1_HUMAN
|
Increases Expression
|
[18] |
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (ST6GALNAC3)
|
OTLAQ14Q
|
SIA7C_HUMAN
|
Decreases Expression
|
[18] |
Trinucleotide repeat-containing gene 6A protein (TNRC6A)
|
OT493IOM
|
TNR6A_HUMAN
|
Increases Expression
|
[18] |
Coiled-coil domain-containing protein 112 (CCDC112)
|
OT3OEYG6
|
CC112_HUMAN
|
Increases Expression
|
[18] |
Class E basic helix-loop-helix protein 22 (BHLHE22)
|
OTZUQY5L
|
BHE22_HUMAN
|
Increases Expression
|
[18] |
Secretory carrier-associated membrane protein 5 (SCAMP5)
|
OT9MXA2J
|
SCAM5_HUMAN
|
Increases Expression
|
[18] |
Protein odd-skipped-related 1 (OSR1)
|
OTB19LEQ
|
OSR1_HUMAN
|
Decreases Expression
|
[18] |
DEP domain-containing mTOR-interacting protein (DEPTOR)
|
OTCBP1BT
|
DPTOR_HUMAN
|
Decreases Expression
|
[18] |
Protein MGARP (MGARP)
|
OTL90XO8
|
HUMMR_HUMAN
|
Decreases Expression
|
[18] |
Mucolipin-3 (MCOLN3)
|
OTCRPRVS
|
MCLN3_HUMAN
|
Decreases Expression
|
[18] |
Breast carcinoma-amplified sequence 4 (BCAS4)
|
OT596N5E
|
BCAS4_HUMAN
|
Decreases Expression
|
[18] |
E3 ubiquitin-protein ligase SH3RF2 (SH3RF2)
|
OT2IVOK4
|
SH3R2_HUMAN
|
Decreases Expression
|
[18] |
Docking protein 4 (DOK4)
|
OTUEWLG8
|
DOK4_HUMAN
|
Decreases Expression
|
[18] |
Probable phospholipid-transporting ATPase IM (ATP8B4)
|
OT48TSYO
|
AT8B4_HUMAN
|
Decreases Expression
|
[18] |
Cell migration-inducing and hyaluronan-binding protein (CEMIP)
|
OTK80FYN
|
CEMIP_HUMAN
|
Decreases Expression
|
[18] |
Leucine-rich repeat neuronal protein 4 (LRRN4)
|
OTC2T1MP
|
LRRN4_HUMAN
|
Decreases Expression
|
[18] |
Selenoprotein M (SELENOM)
|
OTJ7PORS
|
SELM_HUMAN
|
Decreases Expression
|
[18] |
Atlastin-1 (ATL1)
|
OTR2788Y
|
ATLA1_HUMAN
|
Increases Expression
|
[18] |
E3 ubiquitin-protein ligase MYLIP (MYLIP)
|
OTL0PFGV
|
MYLIP_HUMAN
|
Decreases Expression
|
[18] |
Cyclic GMP-AMP phosphodiesterase SMPDL3A (SMPDL3A)
|
OTQDYH8E
|
ASM3A_HUMAN
|
Decreases Expression
|
[18] |
SEC14-like protein 1 (SEC14L1)
|
OTA75FET
|
S14L1_HUMAN
|
Decreases Expression
|
[18] |
Protein NDRG1 (NDRG1)
|
OTVO66BO
|
NDRG1_HUMAN
|
Decreases Expression
|
[18] |
Ankyrin repeat and SAM domain-containing protein 1A (ANKS1A)
|
OTYZP3MP
|
ANS1A_HUMAN
|
Decreases Expression
|
[18] |
Serine protease HTRA1 (HTRA1)
|
OTR8ACBF
|
HTRA1_HUMAN
|
Decreases Expression
|
[18] |
Secreted frizzled-related protein 3 (FRZB)
|
OTTO3DPY
|
SFRP3_HUMAN
|
Decreases Expression
|
[18] |
Hyaluronan synthase 2 (HAS2)
|
OTTD3PAL
|
HYAS2_HUMAN
|
Decreases Expression
|
[18] |
Proprotein convertase subtilisin/kexin type 5 (PCSK5)
|
OTP0RJ4Y
|
PCSK5_HUMAN
|
Decreases Expression
|
[18] |
Kallikrein-6 (KLK6)
|
OTIEA234
|
KLK6_HUMAN
|
Decreases Expression
|
[18] |
Exostosin-2 (EXT2)
|
OT8IR5QN
|
EXT2_HUMAN
|
Decreases Expression
|
[18] |
Ecto-ADP-ribosyltransferase 4 (ART4)
|
OTTV2J54
|
NAR4_HUMAN
|
Decreases Expression
|
[18] |
Caveolae-associated protein 3 (CAVIN3)
|
OTOLBK79
|
CAVN3_HUMAN
|
Decreases Expression
|
[18] |
Myeloid-derived growth factor (MYDGF)
|
OT9HRPL6
|
MYDGF_HUMAN
|
Decreases Expression
|
[18] |
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (ST6GALNAC6)
|
OT3C3VWX
|
SIA7F_HUMAN
|
Decreases Expression
|
[18] |
Coiled-coil domain-containing protein 102A (CCDC102A)
|
OTT7XHIP
|
C102A_HUMAN
|
Decreases Expression
|
[18] |
Ras-related and estrogen-regulated growth inhibitor (RERG)
|
OTF6MMLV
|
RERG_HUMAN
|
Decreases Expression
|
[18] |
Ras-related protein Rab-37 (RAB37)
|
OTRL8IUO
|
RAB37_HUMAN
|
Decreases Expression
|
[18] |
Store-operated calcium entry-associated regulatory factor (SARAF)
|
OTH5JIFE
|
SARAF_HUMAN
|
Decreases Expression
|
[18] |
BTB/POZ domain-containing protein KCTD12 (KCTD12)
|
OTPYKT4Z
|
KCD12_HUMAN
|
Decreases Expression
|
[18] |
Multivesicular body subunit 12A (MVB12A)
|
OT3737K0
|
MB12A_HUMAN
|
Decreases Expression
|
[18] |
E3 ubiquitin-protein ligase pellino homolog 1 (PELI1)
|
OTMLBCLC
|
PELI1_HUMAN
|
Increases Expression
|
[18] |
Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL)
|
OT9EIUGH
|
PHIPL_HUMAN
|
Increases Expression
|
[18] |
Multidrug and toxin extrusion protein 1 (SLC47A1)
|
OTZX0U5Q
|
S47A1_HUMAN
|
Decreases Expression
|
[18] |
Vacuolar-sorting protein SNF8 (SNF8)
|
OTRQA2AI
|
SNF8_HUMAN
|
Decreases Expression
|
[18] |
Secreted frizzled-related protein 2 (SFRP2)
|
OT8GZ0CA
|
SFRP2_HUMAN
|
Increases Expression
|
[18] |
PC-esterase domain-containing protein 1B (PCED1B)
|
OT19CDAB
|
PED1B_HUMAN
|
Decreases Expression
|
[18] |
Terminal nucleotidyltransferase 5A (TENT5A)
|
OTSYF511
|
TET5A_HUMAN
|
Decreases Expression
|
[18] |
Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1)
|
OTY5HZN5
|
LRIG1_HUMAN
|
Increases Expression
|
[18] |
Lysyl oxidase homolog 4 (LOXL4)
|
OT6XY2JL
|
LOXL4_HUMAN
|
Decreases Expression
|
[18] |
Multiple epidermal growth factor-like domains protein 10 (MEGF10)
|
OTILSPJ6
|
MEG10_HUMAN
|
Increases Expression
|
[18] |
N-terminal kinase-like protein (SCYL1)
|
OTQ0IN7P
|
SCYL1_HUMAN
|
Decreases Expression
|
[18] |
Ecto-ADP-ribosyltransferase 5 (ART5)
|
OTEZUT8V
|
NAR5_HUMAN
|
Decreases Expression
|
[18] |
Protein phosphatase 1M (PPM1M)
|
OTCPLZQ7
|
PPM1M_HUMAN
|
Decreases Expression
|
[18] |
Roundabout homolog 3 (ROBO3)
|
OTPVG40S
|
ROBO3_HUMAN
|
Increases Expression
|
[18] |
Prickle-like protein 1 (PRICKLE1)
|
OT9HHEM9
|
PRIC1_HUMAN
|
Decreases Expression
|
[18] |
Leucine-rich repeat and fibronectin type-III domain-containing protein 5 (LRFN5)
|
OTK7QZ3B
|
LRFN5_HUMAN
|
Decreases Expression
|
[18] |
Guanylate-binding protein 4 (GBP4)
|
OTSPNGKX
|
GBP4_HUMAN
|
Decreases Expression
|
[18] |
Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (MAGI1)
|
OTMV4ASV
|
MAGI1_HUMAN
|
Increases Expression
|
[18] |
Myeloid-associated differentiation marker (MYADM)
|
OTZTZI7P
|
MYADM_HUMAN
|
Decreases Expression
|
[18] |
Protein Niban 2 (NIBAN2)
|
OTVDQSPI
|
NIBA2_HUMAN
|
Decreases Expression
|
[18] |
Transcription factor 12 (TCF12)
|
OTZVONNU
|
HTF4_HUMAN
|
Increases Expression
|
[18] |
Protein kinase C-binding protein NELL2 (NELL2)
|
OTS4MJZ7
|
NELL2_HUMAN
|
Increases Expression
|
[18] |
G-protein coupled estrogen receptor 1 (GPER1)
|
OTUK0TDC
|
GPER1_HUMAN
|
Decreases Expression
|
[18] |
Pituitary homeobox 2 (PITX2)
|
OTWMXAOY
|
PITX2_HUMAN
|
Decreases Expression
|
[18] |
Plakophilin-2 (PKP2)
|
OTJOVF68
|
PKP2_HUMAN
|
Decreases Expression
|
[18] |
Cbp/p300-interacting transactivator 2 (CITED2)
|
OT812TV7
|
CITE2_HUMAN
|
Decreases Expression
|
[18] |
Ribosome quality control complex subunit TCF25 (TCF25)
|
OTTFHHU9
|
TCF25_HUMAN
|
Decreases Expression
|
[18] |
Allograft inflammatory factor 1-like (AIF1L)
|
OTDEOB80
|
AIF1L_HUMAN
|
Increases Expression
|
[18] |
SH3-containing GRB2-like protein 3-interacting protein 1 (SGIP1)
|
OTQW6R3Z
|
SGIP1_HUMAN
|
Increases Expression
|
[18] |
Transcription elongation factor A protein-like 7 (TCEAL7)
|
OTNPDZCN
|
TCAL7_HUMAN
|
Increases Expression
|
[18] |
Histone H2A.J (H2AJ)
|
OTVA4XTW
|
H2AJ_HUMAN
|
Decreases Expression
|
[18] |
Ribonuclease P protein subunit p25 (RPP25)
|
OTEN6QN7
|
RPP25_HUMAN
|
Decreases Expression
|
[18] |
EF-hand domain-containing protein D1 (EFHD1)
|
OTL5INE4
|
EFHD1_HUMAN
|
Decreases Expression
|
[18] |
Arginine/serine-rich protein 1 (RSRP1)
|
OTOAZLCL
|
RSRP1_HUMAN
|
Decreases Expression
|
[18] |
Transmembrane emp24 domain-containing protein 9 (TMED9)
|
OTYGAQS0
|
TMED9_HUMAN
|
Decreases Expression
|
[18] |
Max dimerization protein 3 (MXD3)
|
OT4U88UP
|
MAD3_HUMAN
|
Increases Expression
|
[18] |
Transcription factor GATA-5 (GATA5)
|
OTO81B63
|
GATA5_HUMAN
|
Decreases Expression
|
[18] |
Oxysterol-binding protein-related protein 10 (OSBPL10)
|
OT0TFMBE
|
OSB10_HUMAN
|
Decreases Expression
|
[18] |
Uncharacterized protein KIAA1671 (KIAA1671)
|
OTYGNSCG
|
K1671_HUMAN
|
Decreases Expression
|
[18] |
Tripartite motif-containing protein 6 (TRIM6)
|
OTBSMX0B
|
TRIM6_HUMAN
|
Decreases Expression
|
[18] |
Tripartite motif-containing protein 5 (TRIM5)
|
OTMZH7EJ
|
TRIM5_HUMAN
|
Decreases Expression
|
[18] |
RNA exonuclease 4 (REXO4)
|
OT2NNFKZ
|
REXO4_HUMAN
|
Decreases Expression
|
[18] |
Disintegrin and metalloproteinase domain-containing protein 19 (ADAM19)
|
OTH88TXU
|
ADA19_HUMAN
|
Decreases Expression
|
[18] |
Cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2)
|
OTVSFHTL
|
CRLD2_HUMAN
|
Decreases Expression
|
[18] |
Gamma-aminobutyric acid receptor-associated protein-like 1 (GABARAPL1)
|
OT4U7SBG
|
GBRL1_HUMAN
|
Decreases Expression
|
[18] |
Small conductance calcium-activated potassium channel protein 2 (KCNN2)
|
OTQVTMK5
|
KCNN2_HUMAN
|
Decreases Expression
|
[18] |
Thiamin pyrophosphokinase 1 (TPK1)
|
OTCHPUD0
|
TPK1_HUMAN
|
Decreases Expression
|
[18] |
SPARC-related modular calcium-binding protein 2 (SMOC2)
|
OTK1EQ49
|
SMOC2_HUMAN
|
Decreases Expression
|
[18] |
Leucine-rich repeat neuronal protein 3 (LRRN3)
|
OT7X0AA7
|
LRRN3_HUMAN
|
Increases Expression
|
[18] |
RWD domain-containing protein 1 (RWDD1)
|
OTVEZWQG
|
RWDD1_HUMAN
|
Increases Expression
|
[18] |
Calcium-binding protein 39-like (CAB39L)
|
OTQEBL0W
|
CB39L_HUMAN
|
Decreases Expression
|
[18] |
Spondin-1 (SPON1)
|
OTC06MY4
|
SPON1_HUMAN
|
Decreases Expression
|
[18] |
Anoctamin-8 (ANO8)
|
OT07SRRX
|
ANO8_HUMAN
|
Increases Expression
|
[18] |
Synaptotagmin-like protein 2 (SYTL2)
|
OTUIOWKL
|
SYTL2_HUMAN
|
Increases Expression
|
[18] |
Solute carrier family 40 member 1 (SLC40A1)
|
OT8RV2VY
|
S40A1_HUMAN
|
Decreases Expression
|
[18] |
Zinc transporter ZIP2 (SLC39A2)
|
OTE0GI4W
|
S39A2_HUMAN
|
Decreases Expression
|
[18] |
NADPH oxidase 4 (NOX4)
|
OTTYQ097
|
NOX4_HUMAN
|
Decreases Expression
|
[18] |
Nuclear receptor-interacting protein 3 (NRIP3)
|
OTU15GMK
|
NRIP3_HUMAN
|
Decreases Expression
|
[18] |
G-protein coupled receptor family C group 5 member C (GPRC5C)
|
OT45AJT3
|
GPC5C_HUMAN
|
Decreases Expression
|
[18] |
PR domain zinc finger protein 8 (PRDM8)
|
OTRA3265
|
PRDM8_HUMAN
|
Increases Expression
|
[18] |
Integral membrane protein 2C (ITM2C)
|
OTHVMXE3
|
ITM2C_HUMAN
|
Decreases Expression
|
[18] |
Rho guanine nucleotide exchange factor 3 (ARHGEF3)
|
OTHGNC0A
|
ARHG3_HUMAN
|
Decreases Expression
|
[18] |
Olfactomedin-like protein 3 (OLFML3)
|
OTDN45FN
|
OLFL3_HUMAN
|
Decreases Expression
|
[18] |
Kinesin-like protein KIF15 (KIF15)
|
OTJRJEXL
|
KIF15_HUMAN
|
Increases Expression
|
[18] |
Serine palmitoyltransferase 3 (SPTLC3)
|
OTZDX6PT
|
SPTC3_HUMAN
|
Decreases Expression
|
[18] |
Transmembrane protein 45A (TMEM45A)
|
OT54KJG6
|
TM45A_HUMAN
|
Decreases Expression
|
[18] |
Host cell factor C1 regulator 1 (HCFC1R1)
|
OTGDPS5C
|
HPIP_HUMAN
|
Decreases Expression
|
[18] |
Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase (BPNT2)
|
OT65C86U
|
IMPA3_HUMAN
|
Decreases Expression
|
[18] |
PH and SEC7 domain-containing protein 3 (PSD3)
|
OTTN9B9O
|
PSD3_HUMAN
|
Increases Expression
|
[18] |
G-protein coupled receptor 83 (GPR83)
|
OT7A2FE8
|
GPR83_HUMAN
|
Decreases Expression
|
[18] |
Podocalyxin-like protein 2 (PODXL2)
|
OTB3PUR8
|
PDXL2_HUMAN
|
Increases Expression
|
[18] |
Ral guanine nucleotide dissociation stimulator-like 1 (RGL1)
|
OTY6ZHVA
|
RGL1_HUMAN
|
Decreases Expression
|
[18] |
Myoferlin (MYOF)
|
OTRFC3IJ
|
MYOF_HUMAN
|
Decreases Expression
|
[18] |
Low-density lipoprotein receptor-related protein 1B (LRP1B)
|
OT4YZG2N
|
LRP1B_HUMAN
|
Decreases Expression
|
[18] |
LIM and cysteine-rich domains protein 1 (LMCD1)
|
OT3AWE8O
|
LMCD1_HUMAN
|
Decreases Expression
|
[18] |
Protein PALS2 (PALS2)
|
OTV12NKE
|
PALS2_HUMAN
|
Decreases Expression
|
[18] |
Spermatogenesis-associated protein 7 (SPATA7)
|
OT78G2IH
|
SPAT7_HUMAN
|
Increases Expression
|
[18] |
Neurotrimin (NTM)
|
OTHF0UQU
|
NTRI_HUMAN
|
Decreases Expression
|
[18] |
C-type lectin domain family 1 member B (CLEC1B)
|
OTO38TRG
|
CLC1B_HUMAN
|
Decreases Expression
|
[18] |
Dynein axonemal heavy chain 2 (DNAH2)
|
OT7J5LDI
|
DYH2_HUMAN
|
Decreases Expression
|
[18] |
Semaphorin-5B (SEMA5B)
|
OTUVSKK0
|
SEM5B_HUMAN
|
Increases Expression
|
[18] |
Signal-induced proliferation-associated 1-like protein 2 (SIPA1L2)
|
OT8NJE5D
|
SI1L2_HUMAN
|
Decreases Expression
|
[18] |
Protein dispatched homolog 3 (DISP3)
|
OTEW6RYT
|
DISP3_HUMAN
|
Increases Expression
|
[18] |
A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAMTS9)
|
OTV3Q0DS
|
ATS9_HUMAN
|
Decreases Expression
|
[18] |
Vesicular glutamate transporter 2 (SLC17A6)
|
OTP1MJGP
|
VGLU2_HUMAN
|
Increases Expression
|
[18] |
Beta-1,4-galactosyltransferase 7 (B4GALT7)
|
OTG5WHRW
|
B4GT7_HUMAN
|
Decreases Expression
|
[18] |
Tachykinin-3 (TAC3)
|
OTOJGM38
|
TKNK_HUMAN
|
Decreases Expression
|
[18] |
A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1)
|
OTTLJH8W
|
ATS1_HUMAN
|
Decreases Expression
|
[18] |
Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAIAP2L1)
|
OTZ71SK9
|
BI2L1_HUMAN
|
Decreases Expression
|
[18] |
SERTA domain-containing protein 1 (SERTAD1)
|
OTBHKZQP
|
SRTD1_HUMAN
|
Decreases Expression
|
[18] |
F-box only protein 2 (FBXO2)
|
OTF3677S
|
FBX2_HUMAN
|
Decreases Expression
|
[18] |
Angiopoietin-related protein 2 (ANGPTL2)
|
OTB6JG41
|
ANGL2_HUMAN
|
Decreases Expression
|
[18] |
Microtubule-associated tumor suppressor 1 (MTUS1)
|
OTBPALMU
|
MTUS1_HUMAN
|
Increases Expression
|
[18] |
Y+L amino acid transporter 1 (SLC7A7)
|
OTYNABBR
|
YLAT1_HUMAN
|
Decreases Expression
|
[18] |
Lysosomal thioesterase PPT2 (PPT2)
|
OTD5VJ9A
|
PPT2_HUMAN
|
Decreases Expression
|
[18] |
Protein NDRG2 (NDRG2)
|
OT5L6KD7
|
NDRG2_HUMAN
|
Decreases Expression
|
[18] |
LIM and calponin homology domains-containing protein 1 (LIMCH1)
|
OTYPC4XA
|
LIMC1_HUMAN
|
Increases Expression
|
[18] |
Type 2 lactosamine alpha-2,3-sialyltransferase (ST3GAL6)
|
OTB17Q43
|
SIA10_HUMAN
|
Decreases Expression
|
[18] |
Nuclease EXOG, mitochondrial (EXOG)
|
OTZAI8L7
|
EXOG_HUMAN
|
Decreases Expression
|
[18] |
Netrin-G1 (NTNG1)
|
OTF48IID
|
NTNG1_HUMAN
|
Increases Expression
|
[18] |
Protein SSUH2 homolog (SSUH2)
|
OTWUBDV0
|
SSUH2_HUMAN
|
Increases Expression
|
[18] |
Transmembrane protein 98 (TMEM98)
|
OTKDUEED
|
TMM98_HUMAN
|
Decreases Expression
|
[18] |
Plasmolipin (PLLP)
|
OTFGCB9U
|
PLLP_HUMAN
|
Decreases Expression
|
[18] |
C2 domain-containing protein 2 (C2CD2)
|
OTL1K0OB
|
C2CD2_HUMAN
|
Decreases Expression
|
[18] |
Talin-2 (TLN2)
|
OT10QQBC
|
TLN2_HUMAN
|
Decreases Expression
|
[18] |
Protein mab-21-like 2 (MAB21L2)
|
OTZM5VMX
|
MB212_HUMAN
|
Decreases Expression
|
[18] |
Transient receptor potential cation channel subfamily V member 2 (TRPV2)
|
OT0A9AVD
|
TRPV2_HUMAN
|
Decreases Expression
|
[18] |
Transcription factor SOX-21 (SOX21)
|
OTNT50CC
|
SOX21_HUMAN
|
Increases Expression
|
[18] |
LHFPL tetraspan subfamily member 6 protein (LHFPL6)
|
OTY6LHJY
|
LHPL6_HUMAN
|
Increases Expression
|
[18] |
Stonin-1 (STON1)
|
OT2HPUAI
|
STON1_HUMAN
|
Decreases Expression
|
[18] |
Transcription factor E2F8 (E2F8)
|
OTQKZGFP
|
E2F8_HUMAN
|
Increases Expression
|
[20] |
Thymidine kinase 2, mitochondrial (TK2)
|
OTS1V4XB
|
KITM_HUMAN
|
Decreases Expression
|
[34] |
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)
|
OTA1CPBV
|
TR10B_HUMAN
|
Increases Expression
|
[35] |
Protein regulator of cytokinesis 1 (PRC1)
|
OTHD0XS0
|
PRC1_HUMAN
|
Decreases Expression
|
[19] |
PRA1 family protein 3 (ARL6IP5)
|
OTYZ6BEQ
|
PRAF3_HUMAN
|
Increases Expression
|
[36] |
Prothrombin (F2)
|
OTNFSM49
|
THRB_HUMAN
|
Affects Expression
|
[37] |
Plasminogen (PLG)
|
OTWWIPPY
|
PLMN_HUMAN
|
Affects Localization
|
[38] |
Prolactin (PRL)
|
OTWFQGX7
|
PRL_HUMAN
|
Increases Expression
|
[39] |
Tumor necrosis factor (TNF)
|
OT4IE164
|
TNFA_HUMAN
|
Increases Expression
|
[40] |
Thymidine kinase, cytosolic (TK1)
|
OTY5JFM1
|
KITH_HUMAN
|
Decreases Expression
|
[34] |
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
|
OTBPMIMW
|
G3P_HUMAN
|
Decreases Activity
|
[41] |
Interleukin-6 (IL6)
|
OTUOSCCU
|
IL6_HUMAN
|
Increases Expression
|
[40] |
Transcription factor Jun (JUN)
|
OTCYBO6X
|
JUN_HUMAN
|
Increases Expression
|
[42] |
High mobility group protein B1 (HMGB1)
|
OT4B7CPF
|
HMGB1_HUMAN
|
Increases Secretion
|
[43] |
Poly polymerase 1 (PARP1)
|
OT310QSG
|
PARP1_HUMAN
|
Increases Degradation
|
[44] |
Apoptosis regulator Bcl-2 (BCL2)
|
OT9DVHC0
|
BCL2_HUMAN
|
Decreases Expression
|
[42] |
Histone H2AX (H2AX)
|
OT18UX57
|
H2AX_HUMAN
|
Increases Phosphorylation
|
[41] |
Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A)
|
OTDRV63V
|
GA45A_HUMAN
|
Increases Expression
|
[20] |
Tumor necrosis factor receptor superfamily member 6 (FAS)
|
OTP9XG86
|
TNR6_HUMAN
|
Increases Expression
|
[20] |
Cyclin-dependent kinases regulatory subunit 2 (CKS2)
|
OTPTMHIV
|
CKS2_HUMAN
|
Decreases Expression
|
[19] |
Cyclin-dependent kinase inhibitor 1 (CDKN1A)
|
OTQWHCZE
|
CDN1A_HUMAN
|
Increases Expression
|
[20] |
Caspase-3 (CASP3)
|
OTIJRBE7
|
CASP3_HUMAN
|
Increases Activity
|
[45] |
Importin subunit alpha-1 (KPNA2)
|
OTU7FOE6
|
IMA1_HUMAN
|
Decreases Expression
|
[19] |
Sestrin-3 (SESN3)
|
OTJRY1Y5
|
SESN3_HUMAN
|
Decreases Expression
|
[20] |
Beta-2-microglobulin (B2M)
|
OTDWN6NX
|
B2MG_HUMAN
|
Increases Expression
|
[46] |
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 (PLCB2)
|
OTPAHDGO
|
PLCB2_HUMAN
|
Affects Localization
|
[47] |
Transcription factor p65 (RELA)
|
OTUJP9CN
|
TF65_HUMAN
|
Decreases Activity
|
[48] |
Apoptosis regulator BAX (BAX)
|
OTAW0V4V
|
BAX_HUMAN
|
Increases Expression
|
[49] |
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1)
|
OT2YYI1A
|
MCL1_HUMAN
|
Decreases Expression
|
[50] |
Cyclin-dependent kinase 5 activator 1 (CDK5R1)
|
OTJELWK0
|
CD5R1_HUMAN
|
Increases Expression
|
[20] |
Borealin (CDCA8)
|
OT17D55D
|
BOREA_HUMAN
|
Decreases Expression
|
[19] |
Proline/serine-rich coiled-coil protein 1 (PSRC1)
|
OT7MDJMN
|
PSRC1_HUMAN
|
Decreases Expression
|
[19] |
Protein aurora borealis (BORA)
|
OTV2ZPKP
|
BORA_HUMAN
|
Decreases Expression
|
[19] |
Jouberin (AHI1)
|
OT8K2YWY
|
AHI1_HUMAN
|
Increases Expression
|
[51] |
Transient receptor potential cation channel subfamily V member 1 (TRPV1)
|
OTHHDR03
|
TRPV1_HUMAN
|
Affects Localization
|
[52] |
Tumor necrosis factor receptor superfamily member 19 (TNFRSF19)
|
OTTVT4MB
|
TNR19_HUMAN
|
Decreases Expression
|
[20] |
Solute carrier family 12 member 6 (SLC12A6)
|
OT9CS413
|
S12A6_HUMAN
|
Decreases Expression
|
[20] |
Lactosylceramide alpha-2,3-sialyltransferase (ST3GAL5)
|
OT27CCUF
|
SIAT9_HUMAN
|
Decreases Expression
|
[20] |
Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1)
|
OTJQL0I3
|
HEY1_HUMAN
|
Decreases Expression
|
[20] |
Interleukin-3 (IL3)
|
OT0CQ35N
|
IL3_HUMAN
|
Increases ADR
|
[53] |
Kynurenine 3-monooxygenase (KMO)
|
OT3MRMM9
|
KMO_HUMAN
|
Increases Response To Substance
|
[54] |
Stathmin-4 (STMN4)
|
OT7ZUKW6
|
STMN4_HUMAN
|
Increases Response To Substance
|
[54] |
Histone-lysine N-methyltransferase 2A (KMT2A)
|
OT9GLJI6
|
KMT2A_HUMAN
|
Increases Response To Substance
|
[55] |
Protein lyl-1 (LYL1)
|
OTCNOV1M
|
LYL1_HUMAN
|
Decreases Response To Substance
|
[56] |
Metalloproteinase inhibitor 3 (TIMP3)
|
OTDGQAD1
|
TIMP3_HUMAN
|
Decreases Response To Substance
|
[57] |
Tumor protein p53-inducible protein 11 (TP53I11)
|
OTFPDYZU
|
P5I11_HUMAN
|
Increases Response To Substance
|
[54] |
Hepatocyte growth factor (HGF)
|
OTGHUA23
|
HGF_HUMAN
|
Increases ADR
|
[53] |
Multidrug resistance-associated protein 1 (ABCC1)
|
OTGUN89S
|
MRP1_HUMAN
|
Affects Response To Substance
|
[58] |
Cellular tumor antigen p53 (TP53)
|
OTIE1VH3
|
P53_HUMAN
|
Increases Response To Substance
|
[59] |
14-3-3 protein sigma (SFN)
|
OTLJCZ1U
|
1433S_HUMAN
|
Decreases Response To Substance
|
[60] |
Protein kinase C zeta type (PRKCZ)
|
OTN2FE42
|
KPCZ_HUMAN
|
Decreases Response To Substance
|
[61] |
Calcitonin receptor (CALCR)
|
OTOVDJ7S
|
CALCR_HUMAN
|
Increases Response To Substance
|
[54] |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN)
|
OTOWDUNT
|
PTEN_HUMAN
|
Increases Response To Substance
|
[62] |
Glutathione S-transferase Mu 1 (GSTM1)
|
OTSBF2MO
|
GSTM1_HUMAN
|
Affects Response To Substance
|
[22] |
Methylenetetrahydrofolate reductase (MTHFR)
|
OTUBJSR7
|
MTHR_HUMAN
|
Affects Response To Substance
|
[57] |
Deoxycytidine kinase (DCK)
|
OTW8HLZC
|
DCK_HUMAN
|
Decreases Response To Substance
|
[33] |
------------------------------------------------------------------------------------ |
|
|
|
|